Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients

Archives of Medical Research

Volumn 39, Issue 7, 2008, Pages 702-708

  Menardi, Endrj ^a   Vado, Antonello ^a   Rossetti, Guido ^a   Racca, Emanuela ^a   Conte, Enrica ^a   Deorsola, Antonella ^a   Bobbio, Marco ^a   Feola, Mauro ^b  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b Ospedale SS Trinita'   (Italy)

Author keywords

Heart failure; Natriuretic peptides; Pacing

Indexed keywords

ADRENALIN; BIG ENDOTHELIN 1; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN; FUROSEMIDE; LISINOPRIL; NEUROHORMONE; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY FUNCTION; ECHOCARDIOGRAPHY; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; PROTEIN BLOOD LEVEL;

AGED; CARDIAC PACING, ARTIFICIAL; ENDOTHELINS; EPINEPHRINE; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PACEMAKER, ARTIFICIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49949111314     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.07.004     Document Type: Article

References (30)

1. Hochleitner M., Hortnagl H., Ng C.-K., Hortnagl H., Gschnitzer F., and Zechnamm W. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 66 (1990) 198-202
2. Linde C., Gadler F., Edner M., Nordlander R., Rosenqvist M., and Ryden L. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 75 (1995) 919-923
3. Breker S.J.D., Xiao H.B., Sparrow J., and Gibson D.G. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 340 (1992) 1308-1312
4. Nishimura R.A., Hayes D.L., Holmes D.R., and Tajik A.J. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute doppler and catheterization hemodynamic study. J Am Coll Cardiol 25 (1995) 281-288
5. Coats A.J. MADIT II. The Multi-centre Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?. Int J Cardiol 82 (2002) 1-5
6. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
7. Cleland JGF, JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
8. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., et al. for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
9. Braun M.U., Rauwolf T., Zerm T., Sculze M., Schnabel A., and Strasser R.H. Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones. Heart 91 (2005) 601-605
10. Hernandez Madrid A., Miguelanez Diaz M., Escobar Cervantes C., Blanco Tirados B., Marin I., Bernal E., Zamora J., Cordova Gonzalez F.J., et al. Usefulness of brain natriuretic peptide to evaluate patients with heart failure treated with cardiac resynchronization. Rev Esp Cardiol 57 (2004) 299-305
11. Menardi E., Vado A., Rossetti G., Racca E., Feola M., and Uslenghi E. Biventricular pacing in severe congestive heart failure: effects on neurohormonal assessment. Eur J Heart Fail 3 Suppl 1 (2004) 45-46
12. Murkofsky R.L., Dangas G., Diamod J.A., Metha D., Schaffer A., and Ambrose J.A. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction. J Am Coll Cardiol 32 (1998) 476-482
13. Ansalone G., Giannantoni P., Ricci R., Trambaiolo P., Laurenti A., Fedele F., et al. Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. Am Heart J 142 (2001) 881-896
14. Agricola E., and La Canna G. Effects of biventricular pacing on left ventricular contractile asynchrony in patients with heart failure. Evaluation with echo colour kinesis. G Ital Aritmol Cardiostim 3 (2000) 136-145
15. Zoghbi W.A., Enriquez-Sarano M., Foster E., Grayburn P.A., Kraft C.D., Ra L., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
16. Leclercq C., Victor F., Alonso C., Pavin D., Revault d'Allones G., Bansard J.Y., et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 85 (2000) 1154-1156
17. Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C., et al. for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
18. Opasich C., Pinna G.D., Bobbio M., Sisti M., Demichelis B., Febo O., et al. Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol 31 (1998) 766-775
19. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
20. Feola M., Menardi E., Ribichini F., Vado A., Deorsola A., Ferrero V., et al. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure. Med Sci Monit 9 (2003) 341-345
21. Abraham W.T., Fisher W.G., and Smith A.L. Multicenter InSync Randomized Clinical Evaluation (MIRACLE): results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients. Circulation 104 Suppl II (2001) 618
22. Sutton M.G., Abraham W.T., and Fisher W.G. Cardiac resynchronization results in left ventricular reverse remodelling: evidence from the MIRACLE trial. Circulation 104 suppl II (2001) 617
23. Etienne Y., Mansourati J., Gilard M., Valls-Bertault V., Boschat J., Benditt D.G., et al. Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol 83 (1999) 1138-1140
24. Cappola T.P., Harsch M.R., Jessup M., Abraham W.T., Young J.B., Petersen-Stejskal S., et al. Predictors of remodelling in the CRT era: influence of mitral regurgitation, BNP and gender. J Cardiac Failure 12 (2006) 182-188
25. Karvounis H.I., Dalamag E.G., Papadopoulos C.E., Karamitsos T.D., Vassilikos V., Paraskeevaidis S., et al. Improved papillary muscle function attenuates functional mitral regurgitation in patients with dilated cardiomyopathy after cardiac resynchronization therapy. J Am Soc Echocardiogr 19 (2006) 1150-1157
26. Ypenburg C., Lancellotti P., Tops L., Bleeker G.B., Holma E.R., Pierard L.A., et al. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 50 (2007) 2071-2077
27. Molhoek S.G., Bax J.J., van Erven L., Bootsma M., Steendijk P., Lentjes E., et al. Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy. Heart 90 (2004) 97-98
28. Sinha A.M., Filzmaier K., Breithardt O.A., Kunz D., Graf J., Markus K.U., et al. Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure. Am J Cardiol 91 (2003) 755-758
29. Penicka M., Bartunek J., De Bruyne B., Vanderheyden M., Goethals M., De Zutter M., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
30. Kubanek M., Malek I., Bytesnik J., Fridl P., Riedlbauchova L., Karasova L., et al. Decrease in plasma B-type natriuretic peptide early after iniziation of cardiac resynchronization therapy predicts clinical improvement at 12 months. Eur J Heart Fail 8 (2006) 832-840